Cancer Cell 5 , 231239 (2004)
Because GLP-1 medications slow digestion, researchers have asked whether they might contribute to SIBO or similar less common conditions such as intestinal methanogen overgrowth (IMO)
PlexusDx recommends working with a licensed provider to optimize a single compound based on your genetic profile instead
Weight loss drugs are generally well tolerated
Because of rising type 2 diabetes and obesity rates around the globe, Semaglutide use is skyrocketing
175 Moreover, MDC-22, a phospho-aspirin derivative, has demonstrated strong therapeutic effects by inhibiting EGFR activation and downstream signaling pathways, such as ERK/FAK, and enhancing the efficacy of irinotecan, resulting in reduced tumor growth and extended survival in preclinical models